TCR transgenes and transgene cassettes for TCR gene therapy: Status in 2008

Cancer Immunology, Immunotherapy

Volumn 58, Issue 5, 2009, Pages 809-822

  Uckert, Wolfgang ^a   Schumacher, Ton N M ^b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Adoptive T cell therapy; T lymphocytes; TCR engineering; TCR gene transfer

Indexed keywords

CYSTEINE; RETROVIRUS VECTOR; T LYMPHOCYTE RECEPTOR;

CODON; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SAFETY; T LYMPHOCYTE RECEPTOR GENE; THERAPY EFFECT; TRANSGENE; TUMOR;

ANIMALS; ANTIGENS, NEOPLASM; AUTOIMMUNE DISEASES; CLINICAL TRIALS, PHASE I AS TOPIC; CODON; DIMERIZATION; FEASIBILITY STUDIES; GENE THERAPY; GENES, SYNTHETIC; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MELANOMA; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; RECEPTORS, ANTIGEN, T-CELL; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS; TRANSGENES;

EID: 61349172434     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-008-0649-4     Document Type: Review

References (96)

1. HJ Kolb C Schmid AJ Barrett DJ Schendel 2004 Graft-versus-leukemia reactions in allogeneic chimeras Blood 103 767 776
2. S Gottschalk HE Heslop CM Rooney 2005 Adoptive immunotherapy for EBV-associated malignancies Leuk Lymphoma 46 1 10
3. ME Dudley JR Wunderlich PF Robbins JC Yang P Hwu DJ Schwartzentruber SL Topalian R Sherry NP Restifo AM Hubicki MR Robinson M Raffeld P Duray CA Seipp L Rogers-Freezer KE Morton SA Mavroukakis DE White SA Rosenberg 2002 Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes Science 298 850 854
4. ME Dudley JR Wunderlich JC Yang RM Sherry SL Topalian NP Restifo RE Royal U Kammula DE White SA Mavroukakis LJ Rogers GJ Gracia SA Jones DP Mangiameli MM Pelletier J Gea-Banacloche MR Robinson DM Berman AC Filie A Abati SA Rosenberg 2005 Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma J Clin Oncol 23 2346 2357
5. C Berger MC Jensen PM Lansdorp M Gough C Elliott SR Riddell 2008 Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates J Clin Invest 118 294 305
6. L Gattinoni DJ Powell Jr SA Rosenberg NP Restifo 2006 Adoptive immunotherapy for cancer: building on success Nat Rev Immunol 6 383 393
7. Z Dembic W Haas S Weiss J McCubrey H Kiefer H von Boehmer M Steinmetz 1986 Transfer of specificity by murine alpha and beta T-cell receptor genes Nature 320 232 238
8. HW Kessels MC Wolkers MD van den Boom MA van der Valk TN Schumacher 2001 Immunotherapy through TCR gene transfer Nat Immunol 2 957 961
9. JD Abad C Wrzensinski W Overwijk MA De Witte A Jorritsma C Hsu L Gattinoni CJ Cohen CM Paulos DC Palmer JB Haanen TN Schumacher SA Rosenberg NP Restifo RA Morgan 2008 T-cell receptor gene therapy of established tumors in a murine melanoma model J Immunother 31 1 6
10. MA de Witte GM Bendle MD van den Boom M Coccoris TD Schell SS Tevethia H van Tinteren EM Mesman JY Song TN Schumacher 2008 TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation J Immunol 181 2563 2571
11. MA de Witte M Coccoris MC Wolkers MD van den Boom EM Mesman JY Song M van der Valk JB Haanen TN Schumacher 2006 Targeting self-antigens through allogeneic TCR gene transfer Blood 108 870 877
12. M Coccoris E Swart MA de Witte JW van Heijst JB Haanen K Schepers TN Schumacher 2008 Long-term functionality of TCR-transduced T cells in vivo J Immunol 180 6536 6543
13. HW Kessels K Schepers MD van den Boom DJ Topham TN Schumacher 2006 Generation of T cell help through a MHC class I-restricted TCR J Immunol 177 976 982
14. EC Morris A Tsallios GM Bendle SA Xue HJ Stauss 2005 A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection Proc Natl Acad Sci USA 102 7934 7939
15. RA Morgan ME Dudley JR Wunderlich MS Hughes JC Yang RM Sherry RE Royal SL Topalian US Kammula NP Restifo Z Zheng A Nahvi CR de Vries LJ Rogers-Freezer SA Mavroukakis SA Rosenberg 2006 Cancer regression in patients after transfer of genetically engineered lymphocytes Science 314 126 129
16. Kaneko S, Mastaglio S, Bondanza A, Ponzoni M, Sanvito F, Aldrighetti L, Radrizzani M, La Seta-Catamancio S, Provasi E, Mondino A, Nagasawa T, Fleischhauer K, Russo V, Traversari C, Ciceri F, Bordignon C, Bonini C (2008) IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes. Blood [epub ahead of print]. doi: 10.1182/blood-2008-05-156059
17. P Muranski A Boni C Wrzesinski DE Citrin SA Rosenberg R Childs NP Restifo 2006 Increased intensity lymphodepletion and adoptive immunotherapy-how far can we go? Nat Clin Pract Oncol 3 668 681
18. MA de Witte A Jorritsma A Kaiser MD van den Boom M Dokter GM Bendle JB Haanen TN Schumacher 2008 Requirements for effective anti-tumor responses of TCR transduced T cells J Immunol 181 5128 5136
19. S Newrzela K Cornils Z Li C Baum MH Brugman M Hartmann J Meyer S Hartmann ML Hansmann B Fehse D von Laer 2008 Resistance of mature T cells to oncogene transformation Blood 112 2278 2286
20. MH Heemskerk M Hoogeboom R Hagedoorn MG Kester R Willemze JH Falkenburg 2004 Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer J Exp Med 199 885 894
21. LT van der Veken RS Hagedoorn MM van Loenen R Willemze JH Falkenburg MH Heemskerk 2006 Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity Cancer Res 66 3331 3337
22. M Coccoris MA de Witte TN Schumacher 2005 Prospects and limitations of T cell receptor gene therapy Curr Gene Ther 5 583 593
23. B Engels W Uckert 2007 Redirecting T lymphocyte specificity by T cell receptor gene transfer-a new era for immunotherapy Mol Aspects Med 28 115 142
24. MH Heemskerk M Griffioen JH Falkenburg 2008 T-cell receptor gene transfer for treatment of leukemia Cytotherapy 10 108 115
25. TN Schumacher 2002 T-cell-receptor gene therapy Nat Rev Immunol 2 512 519
26. HJ Stauss M Cesco-Gaspere S Thomas DP Hart SA Xue A Holler G Wright M Perro AM Little C Pospori J King EC Morris 2007 Monoclonal T-cell receptors: new reagents for cancer therapy Mol Ther 15 1744 1750
27. N Labrecque LS Whitfield R Obst C Waltzinger C Benoist D Mathis 2001 How much TCR does a T cell need? Immunity 15 71 82
28. M Weinhold D Sommermeyer W Uckert T Blankenstein 2007 Dual T cell receptor expressing CD8+ T cells with tumor- and self-specificity can inhibit tumor growth without causing severe autoimmunity J Immunol 179 5534 5542
29. JS Lam ME Reeves R Cowherd SA Rosenberg P Hwu 1996 Improved gene transfer into human lymphocytes using retroviruses with the gibbon ape leukemia virus envelope Hum Gene Ther 7 1415 1422
30. W Uckert C Becker M Gladow D Klein T Kammertoens L Pedersen T Blankenstein 2000 Efficient gene transfer into primary human CD8+ T lymphocytes by MuLV-10A1 retrovirus pseudotype Hum Gene Ther 11 1005 1014
31. AB Hagani I Riviere C Tan A Krause M Sadelain 1999 Activation conditions determine susceptibility of murine primary T-lymphocytes to retroviral infection J Gene Med 1 341 351
32. B Engels H Cam T Schuler S Indraccolo M Gladow C Baum T Blankenstein W Uckert 2003 Retroviral vectors for high-level transgene expression in T lymphocytes Hum Gene Ther 14 1155 1168
33. A Jorritsma R Gomez-Eerland M Dokter W van de Kasteele YM Zoet II Doxiadis N Rufer P Romero RA Morgan TN Schumacher JB Haanen 2007 Selecting highly affine and well-expressed TCRs for gene therapy of melanoma Blood 110 3564 3572
34. T Tsuji M Yasukawa J Matsuzaki T Ohkuri K Chamoto D Wakita T Azuma H Niiya H Miyoshi K Kuzushima Y Oka H Sugiyama H Ikeda T Nishimura 2005 Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes Blood 106 470 476
35. A Joseph JH Zheng A Follenzi T Dilorenzo K Sango J Hyman K Chen A Piechocka-Trocha C Brander E Hooijberg DA Vignali BD Walker H Goldstein 2008 Lentiviral vectors encoding human immunodeficiency virus type 1 (HIV-1)-specific T-cell receptor genes efficiently convert peripheral blood CD8 T lymphocytes into cytotoxic T lymphocytes with potent in vitro and in vivo HIV-1-specific inhibitory activity J Virol 82 3078 3089
36. S Yang CJ Cohen PD Peng Y Zhao L Cassard Z Yu Z Zheng S Jones NP Restifo SA Rosenberg RA Morgan 2008 Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition Gene Ther 15 1411 1423
37. M Amendola MA Venneri A Biffi E Vigna L Naldini 2005 Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters Nat Biotechnol 23 108 116
38. D Unutmaz VN KewalRamani S Marmon DR Littman 1999 Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes J Exp Med 189 1735 1746
39. SI Thornhill A Schambach SJ Howe M Ulaganathan E Grassman D Williams B Schiedlmeier NJ Sebire HB Gaspar C Kinnon C Baum AJ Thrasher 2008 Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency Mol Ther 16 590 598
40. Y Zhao Z Zheng CJ Cohen L Gattinoni DC Palmer NP Restifo SA Rosenberg RA Morgan 2006 High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation Mol Ther 13 151 159
41. N Schaft J Dorrie I Muller V Beck S Baumann T Schunder E Kampgen G Schuler 2006 A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes Cancer Immunol Immunother 55 1132 1141
42. X Huang AC Wilber L Bao D Tuong J Tolar PJ Orchard BL Levine CH June RS McIvor BR Blazar X Zhou 2006 Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system Blood 107 483 491
43. M Emerman HM Temin 1984 Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism Cell 39 449 467
44. Rubinstein MP, Salem ML, Kadima AN, Nguyen CL, Gillanders WE, Nishimura MI, Cole DJ (2008) Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivo. Cancer Gene Ther [epub ahead of print]. doi: 10.1038/cgt.2008.63
45. IR Ghattas JR Sanes JE Majors 1991 The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos Mol Cell Biol 11 5848 5859
46. MS Hughes YY Yu ME Dudley Z Zheng PF Robbins Y Li J Wunderlich RG Hawley M Moayeri SA Rosenberg RA Morgan 2005 Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions Hum Gene Ther 16 457 472
47. J Holst KM Vignali AR Burton DA Vignali 2006 Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice Nat Methods 3 191 197
48. KB Scholten D Kramer EW Kueter M Graf T Schoedl CJ Meijer MW Schreurs E Hooijberg 2006 Codon modification of T cell receptors allows enhanced functional expression in transgenic human T cells Clin Immunol 119 135 145
49. P de Felipe V Martin ML Cortes M Ryan M Izquierdo 1999 Use of the 2A sequence from foot-and-mouth disease virus in the generation of retroviral vectors for gene therapy Gene Ther 6 198 208
50. H Klump B Schiedlmeier B Vogt M Ryan W Ostertag C Baum 2001 Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy Gene Ther 8 811 817
51. M Leisegang B Engels P Meyerhuber E Kieback D Sommermeyer SA Xue S Reuss H Stauss W Uckert 2008 Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette J Mol Med 86 573 583
52. Theoret MR, Cohen CJ, Nahvi AV, Ngo LT, Suri KB, Powell DJ, Dudley ME, Morgan RA, Rosenberg SA (2008) Relationship of p53 overexpression on cancers and recognition by anti-p53 TCR transduced T cells. Hum Gene Ther (epub ahead of print). doi: 10.1089/hgt.2008.083
53. Y Li R Moysey PE Molloy AL Vuidepot T Mahon E Baston S Dunn N Liddy J Jacob BK Jakobsen JM Boulter 2005 Directed evolution of human T-cell receptors with picomolar affinities by phage display Nat Biotechnol 23 349 354
54. MH Heemskerk M Hoogeboom RA de Paus MG Kester MA van der Hoorn E Goulmy R Willemze JH Falkenburg 2003 Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region Blood 102 3530 3540
55. T Stanislawski RH Voss C Lotz E Sadovnikova RA Willemsen J Kuball T Ruppert RL Bolhuis CJ Melief C Huber HJ Stauss M Theobald 2001 Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer Nat Immunol 2 962 970
56. JK Sandberg K Karre R Glas 1999 Recognition of the major histocompatibility complex restriction element modulates CD8(+) T cell specificity and compensates for loss of T cell receptor contacts with the specific peptide J Exp Med 189 883 894
57. E Sadovnikova HJ Stauss 1996 Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: reagents for tumor immunotherapy Proc Natl Acad Sci USA 93 13114 13118
58. PD Holler PO Holman EV Shusta S O'Herrin KD Wittrup DM Kranz 2000 In vitro evolution of a T cell receptor with high affinity for peptide/MHC Proc Natl Acad Sci USA 97 5387 5392
59. HW Kessels MD n Boom H Spits E Hooijberg TN Schumacher 2000 Changing T cell specificity by retroviral T cell receptor display Proc Natl Acad Sci USA 97 14578 14583
60. SA Richman DM Kranz 2007 Display, engineering, and applications of antigen-specific T cell receptors Biomol Eng 24 361 373
61. Y Zhao AD Bennett Z Zheng QJ Wang PF Robbins LY Yu Y Li PE Molloy SM Dunn BK Jakobsen SA Rosenberg RA Morgan 2007 High-affinity TCRs generated by phage display provide CD4 + T cells with the ability to recognize and kill tumor cell lines J Immunol 179 5845 5854
62. PF Robbins YF Li M El-Gamil Y Zhao JA Wargo Z Zheng H Xu RA Morgan SA Feldman LA Johnson AD Bennett SM Dunn TM Mahon BK Jakobsen SA Rosenberg 2008 Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions J Immunol 180 6116 6131
63. PD Holler LK Chlewicki DM Kranz 2003 TCRs with high affinity for foreign pMHC show self-reactivity Nat Immunol 4 55 62
64. KS Weber DL Donermeyer PM Allen DM Kranz 2005 Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function Proc Natl Acad Sci USA 102 19033 19038
65. DL Donermeyer KS Weber DM Kranz PM Allen 2006 The study of high-affinity TCRs reveals duality in T cell recognition of antigen: specificity and degeneracy J Immunol 177 6911 6919
66. D Sommermeyer J Neudorfer M Weinhold M Leisegang B Engels E Noessner MH Heemskerk J Charo DJ Schendel T Blankenstein H Bernhard W Uckert 2006 Designer T cells by T cell receptor replacement Eur J Immunol 36 3052 3059
67. RH Voss J Kuball R Engel P Guillaume P Romero C Huber M Theobald 2006 Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expression Immunol Res 34 67 87
68. CJ Cohen Y Zhao Z Zheng SA Rosenberg RA Morgan 2006 Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability Cancer Res 66 8878 8886
69. DP Hart SA Xue S Thomas M Cesco-Gaspere A Tranter B Willcox SP Lee N Steven EC Morris HJ Stauss 2008 Retroviral transfer of a dominant TCR prevents surface expression of a large proportion of the endogenous TCR repertoire in human T cells Gene Ther 15 625 631
70. J Kuball ML Dossett M Wolfl WY Ho RH Voss C Fowler PD Greenberg 2007 Facilitating matched pairing and expression of TCR chains introduced into human T cells Blood 109 2331 2338
71. CJ Cohen YF Li M El-Gamil PF Robbins SA Rosenberg RA Morgan 2007 Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond Cancer Res 67 3898 3903
72. S Thomas SA Xue M Cesco-Gaspere E San Jose DP Hart V Wong R Debets B Alarcon E Morris HJ Stauss 2007 Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells J Immunol 179 5803 5810
73. MH Heemskerk RS Hagedoorn MA van der Hoorn LT van der Veken M Hoogeboom MG Kester R Willemze JH Falkenburg 2007 Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex Blood 109 235 243
74. RH Voss RA Willemsen J Kuball M Grabowski R Engel RS Intan P Guillaume P Romero C Huber M Theobald 2008 Molecular design of the Calphabeta interface favors specific pairing of introduced TCRalphabeta in human T cells J Immunol 180 391 401
75. Z Sebestyen E Schooten T Sals I Zaldivar E San Jose B Alarcon S Bobisse A Rosato J Szollosi JW Gratama RA Willemsen R Debets 2008 Human TCR that incorporate CD3zeta induce highly preferred pairing between TCRalpha and beta chains following gene transfer J Immunol 180 7736 7746
76. T Zhang X He TC Tsang DT Harris 2004 Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function Cancer Gene Ther 11 487 496
77. CH Lamers SC Langeveld CM Groot-van Ruijven R Debets S Sleijfer JW Gratama 2007 Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo Cancer Immunol Immunother 56 1875 1883
78. F Ciceri C Bonini C Gallo-Stampino C Bordignon 2005 Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation Cytotherapy 7 144 149
79. C Bonini A Bondanza SK Perna S Kaneko C Traversari F Ciceri C Bordignon 2007 The suicide gene therapy challenge: how to improve a successful gene therapy approach Mol Ther 15 1248 1252
80. C Bonini G Ferrari S Verzeletti P Servida E Zappone L Ruggieri M Ponzoni S Rossini F Mavilio C Traversari C Bordignon 1997 HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia Science 276 1719 1724
81. P Tiberghien C Ferrand B Lioure N Milpied R Angonin E Deconinck JM Certoux E Robinet P Saas B Petracca C Juttner CW Reynolds DL Longo P Herve JY Cahn 2001 Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft Blood 97 63 72
82. SR Riddell M Elliott DA Lewinsohn MJ Gilbert L Wilson SA Manley SD Lupton RW Overell TC Reynolds L Corey PD Greenberg 1996 T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients Nat Med 2 216 223
83. C Berger ME Flowers EH Warren SR Riddell 2006 Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation Blood 107 2294 2302
84. C Traversari S Marktel Z Magnani P Mangia V Russo F Ciceri C Bonini C Bordignon 2007 The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies Blood 109 4708 4715
85. O Frank C Rudolph C Heberlein N von Neuhoff E Schrock A Schambach B Schlegelberger B Fehse W Ostertag C Stocking C Baum 2004 Tumor cells escape suicide gene therapy by genetic and epigenetic instability Blood 104 3543 3549
86. M Deschamps P Mercier-Lethondal JM Certoux C Henry B Lioure C Pagneux JY Cahn E Deconinck E Robinet P Tiberghien C Ferrand 2007 Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T cells infused with a hematopoietic graft Blood 110 3842 3852
87. M Introna AM Barbui F Bambacioni C Casati G Gaipa G Borleri S Bernasconi T Barbui J Golay A Biondi A Rambaldi 2000 Genetic modification of human T cells with CD20: a strategy to purify and lyse transduced cells with anti-CD20 antibodies Hum Gene Ther 11 611 620
88. M Serafini M Bonamino J Golay M Introna 2004 Elongation factor 1 (EF1alpha) promoter in a lentiviral backbone improves expression of the CD20 suicide gene in primary T lymphocytes allowing efficient rituximab-mediated lysis Haematologica 89 86 95
89. T van Meerten MJ Claessen A Hagenbeek SB Ebeling 2006 The CD20/alphaCD20 'suicide' system: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells Gene Ther 13 789 797
90. M Serafini M Manganini G Borleri M Bonamino L Imberti A Biondi J Golay A Rambaldi M Introna 2004 Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host disease Hum Gene Ther 15 63 76
91. S Casares AC Stan CA Bona TD Brumeanu 2001 Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II-peptide chimera Nat Biotechnol 19 142 147
92. RR Yuan P Wong MR McDevitt E Doubrovina I Leiner W Bornmann R O'Reilly EG Pamer DA Scheinberg 2004 Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers Blood 104 2397 2402
93. PR Hess C Barnes MD Woolard MD Johnson JM Cullen EJ Collins JA Frelinger 2007 Selective deletion of antigen-specific CD8 + T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin Blood 109 3300 3307
94. MA de Witte A Jorritsma E Swart KC Straathof K de Punder JB Haanen CM Rooney TN Schumacher 2008 An inducible caspase 9 safety switch can halt cell therapy-induced autoimmune disease J Immunol 180 6365 6373
95. E Kieback J Charo D Sommermeyer T Blankenstein W Uckert 2008 A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer Proc Natl Acad Sci USA 105 623 628
96. KC Straathof MA Pule P Yotnda G Dotti EF Vanin MK Brenner HE Heslop DM Spencer CM Rooney 2005 An inducible caspase 9 safety switch for T-cell therapy Blood 105 4247 4254